Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1999 May;54(5):444–451. doi: 10.1136/thx.54.5.444

Amyloidosis and the respiratory tract

J Gillmore 1, P Hawkins 1
PMCID: PMC1763786  PMID: 10212113

Full Text

The Full Text of this article is available as a PDF (182.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axelrad M. A., Kisilevsky R., Willmer J., Chen S. J., Skinner M. Further characterization of amyloid-enhancing factor. Lab Invest. 1982 Aug;47(2):139–146. [PubMed] [Google Scholar]
  2. Ayuso M. C., Gilabert R., Bombi J. A., Salvador A. CT appearance of localized pulmonary amyloidosis. J Comput Assist Tomogr. 1987 Jan-Feb;11(1):197–199. doi: 10.1097/00004728-198701000-00050. [DOI] [PubMed] [Google Scholar]
  3. Berg A. M., Troxler R. F., Grillone G., Kasznica J., Kane K., Cohen A. S., Skinner M. Localized amyloidosis of the larynx: evidence for light chain composition. Ann Otol Rhinol Laryngol. 1993 Nov;102(11):884–889. doi: 10.1177/000348949310201112. [DOI] [PubMed] [Google Scholar]
  4. Bierny J. P. Multinodular primary amyloidosis of the lung; diagnosis by needle biopsy. AJR Am J Roentgenol. 1978 Dec;131(6):1082–1083. doi: 10.2214/ajr.131.6.1082. [DOI] [PubMed] [Google Scholar]
  5. Booth D. R., Sunde M., Bellotti V., Robinson C. V., Hutchinson W. L., Fraser P. E., Hawkins P. N., Dobson C. M., Radford S. E., Blake C. C. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature. 1997 Feb 27;385(6619):787–793. doi: 10.1038/385787a0. [DOI] [PubMed] [Google Scholar]
  6. Botto M., Hawkins P. N., Bickerstaff M. C., Herbert J., Bygrave A. E., McBride A., Hutchinson W. L., Tennent G. A., Walport M. J., Pepys M. B. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. Nat Med. 1997 Aug;3(8):855–859. doi: 10.1038/nm0897-855. [DOI] [PubMed] [Google Scholar]
  7. Breuer R., Simpson G. T., Rubinow A., Skinner M., Cohen A. S. Tracheobronchial amyloidosis: treatment by carbon dioxide laser photoresection. Thorax. 1985 Nov;40(11):870–871. doi: 10.1136/thx.40.11.870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. COTTON R. E., JACKSON J. W. LOCALIZED AMYLOID 'TUMOURS' OF THE LUNG SIMULATING MALIGNANT NEOPLASMS. Thorax. 1964 Mar;19:97–103. doi: 10.1136/thx.19.2.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Celli B. R., Rubinow A., Cohen A. S., Brody J. S. Patterns of pulmonary involvement in systemic amyloidosis. Chest. 1978 Nov;74(5):543–547. doi: 10.1378/chest.74.5.543. [DOI] [PubMed] [Google Scholar]
  10. Chow L. T., Chow W. H., Shum B. S. Fatal massive upper respiratory tract haemorrhage: an unusual complication of localized amyloidosis of the larynx. J Laryngol Otol. 1993 Jan;107(1):51–53. doi: 10.1017/s0022215100122145. [DOI] [PubMed] [Google Scholar]
  11. Comenzo R. L., Vosburgh E., Falk R. H., Sanchorawala V., Reisinger J., Dubrey S., Dember L. M., Berk J. L., Akpek G., LaValley M. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients. Blood. 1998 May 15;91(10):3662–3670. [PubMed] [Google Scholar]
  12. Cordier J. F., Loire R., Brune J. Amyloidosis of the lower respiratory tract. Clinical and pathologic features in a series of 21 patients. Chest. 1986 Dec;90(6):827–831. doi: 10.1378/chest.90.6.827. [DOI] [PubMed] [Google Scholar]
  13. Cueto-Garcia L., Reeder G. S., Kyle R. A., Wood D. L., Seward J. B., Naessens J., Offord K. P., Greipp P. R., Edwards W. D., Tajik A. J. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol. 1985 Oct;6(4):737–743. doi: 10.1016/s0735-1097(85)80475-7. [DOI] [PubMed] [Google Scholar]
  14. D'Arcy F. Localized amyloidosis of the larynx. J Laryngol Otol. 1972 Sep;86(9):929–931. doi: 10.1017/s002221510007609x. [DOI] [PubMed] [Google Scholar]
  15. DUKE M. Tumoral amyloidosis of the lungs; a case report. AMA Arch Pathol. 1959 Jan;67(1):110–117. [PubMed] [Google Scholar]
  16. Dahlgren S. E., Lewenhaupt A., Ovenfors C. O. Fine needle biopsy diagnosis in nodular pulmonary amyloidosis. Acta Pathol Microbiol Scand A. 1970;78(1):1–5. doi: 10.1111/j.1699-0463.1970.tb02122.x. [DOI] [PubMed] [Google Scholar]
  17. Desai R. A., Mahajan V. K., Benjamin S., Van Ordstrand H. S., Cordasco E. M. Pulmonary amyloidoma and hilar adenopathy. Rare manifestations of primary amyloidosis. Chest. 1979 Aug;76(2):170–173. doi: 10.1378/chest.76.2.170. [DOI] [PubMed] [Google Scholar]
  18. Dyke P. C., Demaray M. J., Delavan J. W., Rasmussen R. A. Pulmonary amyloidoma. Am J Clin Pathol. 1974 Feb;61(2):301–305. doi: 10.1093/ajcp/61.2.301. [DOI] [PubMed] [Google Scholar]
  19. Fernandes C. M., Pirie D., Pudifin D. J. Laryngeal amyloidosis. J Laryngol Otol. 1982 Dec;96(12):1165–1175. doi: 10.1017/s0022215100093658. [DOI] [PubMed] [Google Scholar]
  20. Finn D. G., Farmer J. C., Jr Management of amyloidosis of the larynx and trachea. Arch Otolaryngol. 1982 Jan;108(1):54–56. doi: 10.1001/archotol.1982.00790490056017. [DOI] [PubMed] [Google Scholar]
  21. Fukumura M., Mieno T., Suzuki T., Murata Y. Primary diffuse tracheobronchial amyloidosis treated by bronchoscopic Nd-YAG laser irradiation. Jpn J Med. 1990 Nov-Dec;29(6):620–622. doi: 10.2169/internalmedicine1962.29.620. [DOI] [PubMed] [Google Scholar]
  22. García Gallego F., Calleja Canelas J. L. Letter: Hilar enlargement in amyloidosis. N Engl J Med. 1974 Sep 5;291(10):531–531. doi: 10.1056/nejm197409052911016. [DOI] [PubMed] [Google Scholar]
  23. Gillmore J. D., Davies J., Iqbal A., Madhoo S., Russell N. H., Hawkins P. N. Allogeneic bone marrow transplantation for systemic AL amyloidosis. Br J Haematol. 1998 Jan;100(1):226–228. doi: 10.1046/j.1365-2141.1998.00527.x. [DOI] [PubMed] [Google Scholar]
  24. Glenner G. G. Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts). N Engl J Med. 1980 Jun 5;302(23):1283–1292. doi: 10.1056/NEJM198006053022305. [DOI] [PubMed] [Google Scholar]
  25. Glenner G. G. Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts). N Engl J Med. 1980 Jun 12;302(24):1333–1343. doi: 10.1056/NEJM198006123022403. [DOI] [PubMed] [Google Scholar]
  26. Glenner G. G., Eanes E. D., Page D. L. The relation of the properties of Congo red-stained amyloid fibrils to the -conformation. J Histochem Cytochem. 1972 Oct;20(10):821–826. doi: 10.1177/20.10.821. [DOI] [PubMed] [Google Scholar]
  27. Gorevic P. D., Casey T. T., Stone W. J., DiRaimondo C. R., Prelli F. C., Frangione B. Beta-2 microglobulin is an amyloidogenic protein in man. J Clin Invest. 1985 Dec;76(6):2425–2429. doi: 10.1172/JCI112257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Gross B. H. Radiographic manifestations of lymph node involvement in amyloidosis. Radiology. 1981 Jan;138(1):11–14. doi: 10.1148/radiology.138.1.7455070. [DOI] [PubMed] [Google Scholar]
  29. Hamidi Asl K., Liepnieks J. J., Bihrle R., Benson M. D. Local synthesis of amyloid fibril precursor in AL amyloidosis of the urinary tract. Amyloid. 1998 Mar;5(1):49–54. doi: 10.3109/13506129809007290. [DOI] [PubMed] [Google Scholar]
  30. Hawkins P. N., Lavender J. P., Pepys M. B. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component. N Engl J Med. 1990 Aug 23;323(8):508–513. doi: 10.1056/NEJM199008233230803. [DOI] [PubMed] [Google Scholar]
  31. Hawkins P. N., Myers M. J., Lavender J. P., Pepys M. B. Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component. Lancet. 1988 Jun 25;1(8600):1413–1418. doi: 10.1016/s0140-6736(88)92235-0. [DOI] [PubMed] [Google Scholar]
  32. Hawkins P. N., Richardson S., MacSweeney J. E., King A. D., Vigushin D. M., Lavender J. P., Pepys M. B. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression. Q J Med. 1993 Jun;86(6):365–374. [PubMed] [Google Scholar]
  33. Hawkins P. N. Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo. Clin Sci (Lond) 1994 Sep;87(3):289–295. doi: 10.1042/cs0870289. [DOI] [PubMed] [Google Scholar]
  34. Himmelfarb E., Wells S., Rabinowitz J. G. The radiologic spectrum of cardiopulmonary amyloidosis. Chest. 1977 Sep;72(3):327–332. doi: 10.1378/chest.72.3.327. [DOI] [PubMed] [Google Scholar]
  35. Hui A. N., Koss M. N., Hochholzer L., Wehunt W. D. Amyloidosis presenting in the lower respiratory tract. Clinicopathologic, radiologic, immunohistochemical, and histochemical studies on 48 cases. Arch Pathol Lab Med. 1986 Mar;110(3):212–218. [PubMed] [Google Scholar]
  36. Husby G. Nomenclature and classification of amyloid and amyloidoses. J Intern Med. 1992 Dec;232(6):511–512. doi: 10.1111/j.1365-2796.1992.tb00626.x. [DOI] [PubMed] [Google Scholar]
  37. Husebekk A., Skogen B., Husby G., Marhaug G. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol. 1985 Mar;21(3):283–287. doi: 10.1111/j.1365-3083.1985.tb01431.x. [DOI] [PubMed] [Google Scholar]
  38. Inoue S., Hultin P. G., Szarek W. A., Kisilevsky R. Effect of poly(vinylsulfonate) on murine AA amyloid: a high-resolution ultrastructural study. Lab Invest. 1996 Jun;74(6):1081–1090. [PubMed] [Google Scholar]
  39. Jones A. W., Chatterji A. N. Primary tracheobronchial amyloidosis with tracheobronchopathia osteoplastica. Br J Dis Chest. 1977 Oct;71(4):268–272. [PubMed] [Google Scholar]
  40. Kaw Y. T., Esparza A. R. Solitary pleural amyloid nodules occurring as coin lesions diagnosed by fine-needle aspiration biopsy. Diagn Cytopathol. 1991;7(3):304–307. doi: 10.1002/dc.2840070319. [DOI] [PubMed] [Google Scholar]
  41. Kisilevsky R. Anti-amyloid drugs: potential in the treatment of diseases associated with aging. Drugs Aging. 1996 Feb;8(2):75–83. doi: 10.2165/00002512-199608020-00001. [DOI] [PubMed] [Google Scholar]
  42. Kisilevsky R., Lemieux L. J., Fraser P. E., Kong X., Hultin P. G., Szarek W. A. Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease. Nat Med. 1995 Feb;1(2):143–148. doi: 10.1038/nm0295-143. [DOI] [PubMed] [Google Scholar]
  43. Kunze W. P. Senile pulmonary amyloidosis. Pathol Res Pract. 1979 Aug;164(4):413–422. doi: 10.1016/S0344-0338(79)80058-8. [DOI] [PubMed] [Google Scholar]
  44. Kyle R. A., Gertz M. A., Greipp P. R., Witzig T. E., Lust J. A., Lacy M. Q., Therneau T. M. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med. 1997 Apr 24;336(17):1202–1207. doi: 10.1056/NEJM199704243361702. [DOI] [PubMed] [Google Scholar]
  45. Kyle R. A., Gertz M. A. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995 Jan;32(1):45–59. [PubMed] [Google Scholar]
  46. Lee S. C., Johnson H. Multiple nodular pulmonary amyloidosis. A case report and comparison with diffuse alveolar-septal pulmonary amyloidosis. Thorax. 1975 Apr;30(2):178–185. doi: 10.1136/thx.30.2.178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Lewis J. E., Olsen K. D., Kurtin P. J., Kyle R. A. Laryngeal amyloidosis: a clinicopathologic and immunohistochemical review. Otolaryngol Head Neck Surg. 1992 Apr;106(4):372–377. doi: 10.1177/019459989210600410. [DOI] [PubMed] [Google Scholar]
  48. Lorenzo A., Razzaboni B., Weir G. C., Yankner B. A. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature. 1994 Apr 21;368(6473):756–760. doi: 10.1038/368756a0. [DOI] [PubMed] [Google Scholar]
  49. MCALPINE J. C., FULLER A. P. LOCALIZED LARYNGEAL AMYLOIDOSIS, A REPORT OF A CASE WITH A REVIEW OF THE LITERATURE. J Laryngol Otol. 1964 Mar;78:296–314. doi: 10.1017/s0022215100062113. [DOI] [PubMed] [Google Scholar]
  50. McIlwain J. C., Shepperd H. W. Laser treatment of primary amyloidosis of the larynx. J Laryngol Otol. 1986 Sep;100(9):1079–1080. doi: 10.1017/s0022215100100611. [DOI] [PubMed] [Google Scholar]
  51. Mitrani M., Biller H. F. Laryngeal amyloidosis. Laryngoscope. 1985 Nov;95(11):1346–1347. doi: 10.1288/00005537-198511000-00010. [DOI] [PubMed] [Google Scholar]
  52. Mori H., Takio K., Ogawara M., Selkoe D. J. Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. J Biol Chem. 1992 Aug 25;267(24):17082–17086. [PubMed] [Google Scholar]
  53. Nienhuis D. M., Prakash U. B., Edell E. S. Tracheobronchopathia osteochondroplastica. Ann Otol Rhinol Laryngol. 1990 Sep;99(9 Pt 1):689–694. doi: 10.1177/000348949009900903. [DOI] [PubMed] [Google Scholar]
  54. Nugent A. M., Elliott H., McGuigan J. A., Varghese G. Pulmonary amyloidosis: treatment with laser therapy and systemic steroids. Respir Med. 1996 Aug;90(7):433–435. doi: 10.1016/s0954-6111(96)90119-5. [DOI] [PubMed] [Google Scholar]
  55. Pasternak S., White V. A., Gascoyne R. D., Perry S. R., Johnson R. L., Rootman J. Monoclonal origin of localised orbital amyloidosis detected by molecular analysis. Br J Ophthalmol. 1996 Nov;80(11):1013–1017. doi: 10.1136/bjo.80.11.1013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Pepys M. B., Hawkins P. N., Booth D. R., Vigushin D. M., Tennent G. A., Soutar A. K., Totty N., Nguyen O., Blake C. C., Terry C. J. Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature. 1993 Apr 8;362(6420):553–557. doi: 10.1038/362553a0. [DOI] [PubMed] [Google Scholar]
  57. Rubinow A., Celli B. R., Cohen A. S., Rigden B. G., Brody J. S. Localized amyloidosis of the lower respiratory tract. Am Rev Respir Dis. 1978 Sep;118(3):603–611. doi: 10.1164/arrd.1978.118.3.603. [DOI] [PubMed] [Google Scholar]
  58. Rydh A., Suhr O., Hietala S. O., Ahlström K. R., Pepys M. B., Hawkins P. N. Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation. Eur J Nucl Med. 1998 Jul;25(7):709–713. doi: 10.1007/s002590050273. [DOI] [PubMed] [Google Scholar]
  59. Sakula A. Tracheobronchopathia osteoplastica: its relationship to primary tracheobronchial amyloidosis. Thorax. 1968 Jan;23(1):105–110. doi: 10.1136/thx.23.1.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Saraiva M. J., Birken S., Costa P. P., Goodman D. S. Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). J Clin Invest. 1984 Jul;74(1):104–119. doi: 10.1172/JCI111390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Schulz C., Hauck R. W., Nathrath W. B., Präuer H. W., Linke R. P., Emslander H. P. Combined amyloidosis of the upper and lower respiratory tract. Respiration. 1995;62(3):163–166. doi: 10.1159/000196415. [DOI] [PubMed] [Google Scholar]
  62. Smith R. R., Hutchins G. M., Moore G. W., Humphrey R. L. Type and distribution of pulmonary parenchymal and vascular amyloid. Correlation with cardiac amyloid. Am J Med. 1979 Jan;66(1):96–104. doi: 10.1016/0002-9343(79)90488-1. [DOI] [PubMed] [Google Scholar]
  63. Sunde M., Blake C. C. From the globular to the fibrous state: protein structure and structural conversion in amyloid formation. Q Rev Biophys. 1998 Feb;31(1):1–39. doi: 10.1017/s0033583598003400. [DOI] [PubMed] [Google Scholar]
  64. Talbot A. R. Laryngeal amyloidosis. J Laryngol Otol. 1990 Feb;104(2):147–149. doi: 10.1017/s0022215100112113. [DOI] [PubMed] [Google Scholar]
  65. Tan S. Y., Pepys M. B. Amyloidosis. Histopathology. 1994 Nov;25(5):403–414. doi: 10.1111/j.1365-2559.1994.tb00001.x. [DOI] [PubMed] [Google Scholar]
  66. Thompson P. J., Citron K. M. Amyloid and the lower respiratory tract. Thorax. 1983 Feb;38(2):84–87. doi: 10.1136/thx.38.2.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Toyoda M., Ebihara Y., Kato H., Kita S. Tracheobronchial AL amyloidosis: histologic, immunohistochemical, ultrastructural, and immunoelectron microscopic observations. Hum Pathol. 1993 Sep;24(9):970–976. doi: 10.1016/0046-8177(93)90110-3. [DOI] [PubMed] [Google Scholar]
  68. Urban B. A., Fishman E. K., Goldman S. M., Scott W. W., Jr, Jones B., Humphrey R. L., Hruban R. H. CT evaluation of amyloidosis: spectrum of disease. Radiographics. 1993 Nov;13(6):1295–1308. doi: 10.1148/radiographics.13.6.8290725. [DOI] [PubMed] [Google Scholar]
  69. Utz J. P., Swensen S. J., Gertz M. A. Pulmonary amyloidosis. The Mayo Clinic experience from 1980 to 1993. Ann Intern Med. 1996 Feb 15;124(4):407–413. doi: 10.7326/0003-4819-124-4-199602150-00004. [DOI] [PubMed] [Google Scholar]
  70. Walker P. A., Courey M. S., Ossoff R. H. Staged endoscopic treatment of laryngeal amyloidosis. Otolaryngol Head Neck Surg. 1996 Jun;114(6):801–805. doi: 10.1016/S0194-59989670105-5. [DOI] [PubMed] [Google Scholar]
  71. Westermark P., Sletten K., Johansson B., Cornwell G. G., 3rd Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci U S A. 1990 Apr;87(7):2843–2845. doi: 10.1073/pnas.87.7.2843. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES